1) Strategy & Leadership
- CEO Fred Lowery emphasized the importance of operational execution and customer relationships, aiming to accelerate growth and simplify operations.
- The company is focusing on enhancing its technology solutions, particularly through AI-enabled platforms, to improve customer workflows and engagement.
- Leadership changes were made to streamline decision-making and improve execution consistency, with an integrated approach to supply chain and distribution.

2) Financial & Segment Results
- Q2 2026 global sales reached $3.5 billion, reflecting a 6.7% YoY growth.
- Internal local currency sales growth was 4.6%, with non-GAAP operating income up 10.5% and non-GAAP EPS growth of 15.5%.
- U.S. Dental Merchandise sales grew 8.3%, while U.S. Dental Equipment sales declined 1.1% due to tough comparisons from last year.
- International Dental Merchandise sales increased 11.1%, driven by strong performance in Canada and other markets.

3) Operational & Product Plans
- The company is advancing its Henry Schein One technology platforms, with a record number of new Dentrix Ascend customers and a focus on AI integration.
- Plans include implementing shared service functions globally and evaluating the portfolio for higher growth opportunities.
- The Home Solutions business is expanding, with sales growth in the high single digits, reflecting strategic investments in high-growth areas.

4) Guidance & Outlook / Investor Angle
- Full-year 2026 sales growth guidance was raised to 4.5% to 5.5%, up from a previous range of 3% to 5%.
- Non-GAAP diluted EPS is now expected to be between $5.29 and $5.39, reflecting growth of 6% to 8% compared to 2025.
- The company anticipates achieving a $125 million run rate in operating income improvements by the end of 2026, contributing to a long-term goal of $200 million.

5) Problems / Headwinds
- The U.S. Medical segment faced challenges from lower demand for point-of-care diagnostic tests, although overall growth remained solid.
- The company noted that foreign exchange benefits experienced in the first half of 2026 may not continue, impacting future earnings flow-through.

Bottom line: Henry Schein's strong Q2 performance, driven by sales growth and margin improvements, positions the company well for the remainder of 2026. With a focus on technology integration and operational efficiency, the raised guidance reflects confidence in sustained growth and shareholder value creation.